LU70791A1 - - Google Patents

Info

Publication number
LU70791A1
LU70791A1 LU70791A LU70791A LU70791A1 LU 70791 A1 LU70791 A1 LU 70791A1 LU 70791 A LU70791 A LU 70791A LU 70791 A LU70791 A LU 70791A LU 70791 A1 LU70791 A1 LU 70791A1
Authority
LU
Luxembourg
Application number
LU70791A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7333831A external-priority patent/FR2244459A1/fr
Priority claimed from FR7410327A external-priority patent/FR2265386A2/fr
Application filed filed Critical
Publication of LU70791A1 publication Critical patent/LU70791A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU70791A 1973-09-20 1974-08-23 LU70791A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7333831A FR2244459A1 (en) 1973-09-20 1973-09-20 2-Arylamino-pyrimidines - useful as sedatives, antiinflammatory, anti-ulcer, vasodilating, anticholinergic and anti-broncho- constricting agents and diuretics
FR7410327A FR2265386A2 (en) 1974-03-26 1974-03-26 2-Arylamino-pyrimidines - useful as sedatives, antiinflammatory, anti-ulcer, vasodilating, anticholinergic and anti-broncho- constricting agents and diuretics

Publications (1)

Publication Number Publication Date
LU70791A1 true LU70791A1 (de) 1975-06-11

Family

ID=26217948

Family Applications (1)

Application Number Title Priority Date Filing Date
LU70791A LU70791A1 (de) 1973-09-20 1974-08-23

Country Status (12)

Country Link
US (1) US3978055A (de)
JP (1) JPS5088079A (de)
CA (1) CA1008074A (de)
CH (1) CH593266A5 (de)
DE (1) DE2444426A1 (de)
ES (1) ES429869A1 (de)
GB (1) GB1430729A (de)
IT (1) IT1062796B (de)
LU (1) LU70791A1 (de)
NL (1) NL7412494A (de)
SE (1) SE410600B (de)
SU (1) SU645569A3 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1534593A (en) * 1976-09-03 1978-12-06 Soc D Etudes Prod Chimique N-2,6-dichlorophenyl-2-aminopyrimidine and therapeutic compositions containing it
JPS57203072A (en) * 1981-06-05 1982-12-13 Sankyo Co Ltd 4-anilinopyrimidine derivative, its preparation, antidepressant comprising it as active ingredient
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
US5254555A (en) * 1989-10-30 1993-10-19 Beecham Group P.L.C. Amino pyrimidin-7-yl substituted benzopyrans for treatment of hypertension
US7481790B2 (en) * 2000-12-27 2009-01-27 Advanced Cardiovascular Systems, Inc. Vessel enlargement by arteriogenic factor delivery
US20030055263A1 (en) * 2001-07-11 2003-03-20 Boehringer Ingelheim Pharma Kg Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production
DE10133665A1 (de) * 2001-07-11 2003-01-30 Boehringer Ingelheim Pharma Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
WO2004078114A2 (en) * 2003-02-28 2004-09-16 Encysive Pharmaceuticals Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists.
US7320989B2 (en) * 2003-02-28 2008-01-22 Encysive Pharmaceuticals, Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
WO2005047268A2 (en) * 2003-11-10 2005-05-26 X-Ceptor Therapeutics, Inc. Substituted pyrimidine compositions and methods of use
ES2360703T3 (es) 2003-12-03 2011-06-08 Ym Biosciences Australia Pty Ltd Inhibidores de la tubulina.
PL2922828T3 (pl) * 2012-11-21 2020-12-28 Ptc Therapeutics, Inc. Pochodne 4,6-diaminopirymidynowe jako inhibitory bmi-1 w leczeniu raka
TWI692477B (zh) 2013-08-30 2020-05-01 美商Ptc治療公司 經取代嘧啶bmi-1抑制劑
US10584115B2 (en) 2013-11-21 2020-03-10 Ptc Therapeutics, Inc. Substituted pyridine and pyrazine BMI-1 inhibitors
CN104262263B (zh) * 2014-08-29 2017-01-11 西安交通大学 一种N,6二苯基嘧啶-4-胺类Bcr-Abl抑制剂及其制备方法和应用
AU2019340402A1 (en) 2018-08-17 2021-03-25 Ptc Therapeutics, Inc. Method for treating pancreatic cancer
AU2020227748A1 (en) * 2019-02-28 2021-09-16 Ptc Therapeutics, Inc. Method for treating a multiple myeloma
JP2022519930A (ja) * 2019-03-27 2022-03-25 ピーティーシー セラピューティクス, インコーポレイテッド 肉腫を治療する方法に有用な組み合わせ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321478A (en) * 1963-09-20 1967-05-23 American Cyanamid Co Aminoethoxyphenyl amine, ether, and sulfide derivatives of pyrimidine

Also Published As

Publication number Publication date
NL7412494A (nl) 1975-03-24
SU645569A3 (ru) 1979-01-30
CA1008074A (fr) 1977-04-05
DE2444426A1 (de) 1975-03-27
SE7411806L (de) 1975-03-21
CH593266A5 (de) 1977-11-30
SE410600B (sv) 1979-10-22
ES429869A1 (es) 1976-10-01
AU7344174A (en) 1976-03-25
JPS5088079A (de) 1975-07-15
GB1430729A (en) 1976-04-07
IT1062796B (it) 1985-01-31
US3978055A (en) 1976-08-31

Similar Documents

Publication Publication Date Title
AU476761B2 (de)
AU474593B2 (de)
AU474511B2 (de)
AU474838B2 (de)
JPS5088079A (de)
AU465453B2 (de)
AU465434B2 (de)
AU476714B2 (de)
AU472848B2 (de)
AU476696B2 (de)
AR199451A1 (de)
FR2244459B1 (de)
AU477823B2 (de)
AU471461B2 (de)
AR193950A1 (de)
AU476873B1 (de)
AU477824B2 (de)
AU479562A (de)
AU479419A (de)
BG19543A1 (de)
BG19446A1 (de)
BG19004A1 (de)
BG18399A1 (de)
BE810386A (de)
BG20038A1 (de)